NYSE:RDY

72.31
0.49 (0.67%) 1d
0
PAST TOP PICK

(A Top Pick Jan 23/14. Up 18.37%.) Strictly generic. This was a play on India, and fortunately Mr. Modi won the election and things in India have been quite good since then. There have been some corrections along the way and these stocks tend to have a bit of volatility to them. Still likes this and thinks there are good money flows into India.

biotechnology / pharmaceutical
COMMENT

Thinks this can go a little further, simply because the money flows into India are quite enormous right now. A lot of international money managers are looking for places to go where there is a lot of potential, and with the new president in place, money, is flowing into India. He will probably look at trimming his holdings in order to take a little bit of profit, but will keep it as a core position.

biotechnology / pharmaceutical
COMMENT

One of the largest generic drug manufacturers globally. Worldwide, all the healthcare systems are trying to get their costs down. Their numbers are pretty good.

biotechnology / pharmaceutical
TOP PICK

Generic drugs. Facilities are not all in India, but they have low cost production. Half their sales are in North America. The US is going to generic drugs, and we are going to generic drugs, because the cost of hospitalization has to be driven down. This company is a big beneficiary of that.

biotechnology / pharmaceutical
WATCH

The Indian pharma sector is a generic story. In the last year the returns have been the worst in 15 years. He likes the story, but does not know if he likes this one.

biotechnology / pharmaceutical
BUY

Generic drugs. The advantage of this is that its processing is in India so it is a very low cost producer. Have research laboratories in Cambridge in the UK. Looked at this as an opportunity to play generic drugs.

biotechnology / pharmaceutical
TOP PICK

Headquartered in India. Labs are in the Britain and India. FDA approved. Anything produced in these labs can be sold in the US. Obama care is going to generics and this is one of the largest generic manufacturers in the world. A lot of their costs are in the Ruby and this has been clobbered in the last couple of months. India is their third biggest market.

biotechnology / pharmaceutical
WEAK BUY
One of the largest pharmaceutical firms in India. OK as a stock, but he prefers Novartis (NVS-N), which has been around a lot longer.
biotechnology / pharmaceutical
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Dr. Reddy's Laboratories Ltd.(RDY-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Dr. Reddy's Laboratories Ltd. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Dr. Reddy's Laboratories Ltd.(RDY-N) Frequently Asked Questions

What is Dr. Reddy's Laboratories Ltd. stock symbol?

Dr. Reddy's Laboratories Ltd. is a American stock, trading under the symbol RDY-N on the New York Stock Exchange (RDY). It is usually referred to as NYSE:RDY or RDY-N

Is Dr. Reddy's Laboratories Ltd. a buy or a sell?

In the last year, there was no coverage of Dr. Reddy's Laboratories Ltd. published on Stockchase.

Is Dr. Reddy's Laboratories Ltd. a good investment or a top pick?

Dr. Reddy's Laboratories Ltd. was recommended as a Top Pick by on . Read the latest stock experts ratings for Dr. Reddy's Laboratories Ltd..

Why is Dr. Reddy's Laboratories Ltd. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Dr. Reddy's Laboratories Ltd. worth watching?

0 stock analysts on Stockchase covered Dr. Reddy's Laboratories Ltd. In the last year. It is a trending stock that is worth watching.

What is Dr. Reddy's Laboratories Ltd. stock price?

On 2024-03-27, Dr. Reddy's Laboratories Ltd. (RDY-N) stock closed at a price of $72.31.